CSTONE PHARMA-B (02616) spent HKD 2.3143 million to repurchase 500,000 shares on June 18th.
Foundation Medicine-B (02616) announced that it will spend 2.3143 million Hong Kong dollars to repurchase 500,000 shares on June 18, 2026.
CSTONE PHARMA-B (02616) announced on June 18, 2026, that it will buy back 500,000 shares at a cost of HK$2.31 million.
Related Articles
SUNSHINE PHARMA (06887): Zhang Yingjun elected as Chairman of the Board.
.png)
KIMOU ENVIRON (06805) subsidiary signed a construction contract with Guangdong Jinjunda.
GET NICE (00064) announces annual performance, with a net profit attributable to shareholders of HK$53.387 million, a year-on-year increase of 29.66%.
SUNSHINE PHARMA (06887): Zhang Yingjun elected as Chairman of the Board.
KIMOU ENVIRON (06805) subsidiary signed a construction contract with Guangdong Jinjunda.
GET NICE (00064) announces annual performance, with a net profit attributable to shareholders of HK$53.387 million, a year-on-year increase of 29.66%.
RECOMMEND
